Ming-Hui Zou, an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, is the founding director of the Center for Molecular and Translational Medicine at Georgia State.
He holds a doctorate and medical degree and has received prestigious awards from the Juvenile Diabetes Foundation International and the American Heart Association, including the Career Development Award, Irvin H. Page Atherosclerosis Research Award, and National Established Investigator Award.
Zou studies the role of oxidative stress in cardiovascular biology and diseases. He is recognized for making influential discoveries in cardiovascular research, including identifying the role of two key proteins involved in the vessel pathology that leads to vascular diseases and characterizing the AMP-activated kinase (AMPK), a key enzyme in the regulation of energy metabolism, obesity, diabetes, and cardiovascular diseases, as a sensor and regulator of oxidative stress in cardio-metabolic syndromes.
An independent investigator of the National Institutes of Health, the Juvenile Diabetes Research Foundation International (JDRF), and the American Diabetes Association, and a National Scientist Development (SDG) and National Established Investigator (EIA) awardee of the American Heart Association, Zou has used these (and many other awards) to make scientific observations in fields with great potential for immediate clinical relevance.
In the last three years, he has published over 135 peer reviewed papers in highly impacted journals including Nature Medicine, J. Clin. Invest., Circulation., Circulation Research, ATVB, Diabetes, J. Biol. Chem., Hypertension, etc. In 2008, he was elected to the American Society for Clinical Investigation, one of the United States’ oldest honor societies of physician-scientists, membership in which reflects accomplishments by its members at an early stage (under age 45 years old) in their careers.